Answers are grounded in this paper and cite their sources.
Position statement evaluates the role of surrogate outcomes in screening trials, suggesting they cannot replace mortality as the definitive outcome.
Surrogate outcomes may offer earlier evidence of benefit and initiate further evaluative work, but they cannot yet replace mortality as the definitive outcome in cancer screening trials, say Sian Taylor-Phillips and colleagues
No takes yet. Share an insight, caveat, or question.
Batson et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: